PT1075264E - Novas combinacoes farmacologicas de reboxetina e pindolol - Google Patents
Novas combinacoes farmacologicas de reboxetina e pindololInfo
- Publication number
- PT1075264E PT1075264E PT99917309T PT99917309T PT1075264E PT 1075264 E PT1075264 E PT 1075264E PT 99917309 T PT99917309 T PT 99917309T PT 99917309 T PT99917309 T PT 99917309T PT 1075264 E PT1075264 E PT 1075264E
- Authority
- PT
- Portugal
- Prior art keywords
- reboxetine
- pindolol
- disorders
- new pharmacological
- pharmacological combinations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8486098P | 1998-05-08 | 1998-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1075264E true PT1075264E (pt) | 2005-01-31 |
Family
ID=22187677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99917309T PT1075264E (pt) | 1998-05-08 | 1999-04-14 | Novas combinacoes farmacologicas de reboxetina e pindolol |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1075264B1 (pt) |
| JP (1) | JP2002514601A (pt) |
| KR (1) | KR20010052319A (pt) |
| CN (1) | CN1300217A (pt) |
| AT (1) | ATE283694T1 (pt) |
| AU (1) | AU764579B2 (pt) |
| BR (1) | BR9909559A (pt) |
| CA (1) | CA2326105A1 (pt) |
| DE (1) | DE69922367T2 (pt) |
| EA (1) | EA003469B1 (pt) |
| ES (1) | ES2232128T3 (pt) |
| HU (1) | HUP0101341A3 (pt) |
| IL (1) | IL139211A0 (pt) |
| NO (1) | NO20005621D0 (pt) |
| NZ (1) | NZ508035A (pt) |
| PL (1) | PL345351A1 (pt) |
| PT (1) | PT1075264E (pt) |
| SI (1) | SI1075264T1 (pt) |
| SK (1) | SK14502000A3 (pt) |
| TR (1) | TR200003262T2 (pt) |
| WO (1) | WO1999058130A1 (pt) |
| ZA (1) | ZA200005301B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK286669B6 (sk) | 1999-07-01 | 2009-03-05 | Pharmacia & Upjohn Company | Použitie opticky čistého (S,S)-reboxetínu alebo jeho farmaceuticky prijateľnej soli na výrobu lieku na liečenie alebo prevenciu periférnej neuropatie |
| EP1459750B1 (en) * | 1999-07-01 | 2005-06-01 | Pharmacia & Upjohn Company LLC | (S,S)-reboxetine for treating fibromyalgia and other somatoform disorders |
| US20040102440A1 (en) * | 2002-07-01 | 2004-05-27 | Wong Erik Ho Fong | Method of promoting smoking cessation |
| MXPA05000294A (es) | 2002-07-30 | 2005-08-19 | Peter Migaly | Terapia combinada para la depresion, prevencion de suicidios y varias condiciones medicas y psiquiatricas. |
| ATE376419T1 (de) | 2002-12-27 | 2007-11-15 | Otsuka Pharma Co Ltd | Carbostyril-derivate mit selektiven serotonin- aufnahme inhibitoren, zur behandlung von gemütskrankheiten |
| AR042806A1 (es) | 2002-12-27 | 2005-07-06 | Otsuka Pharma Co Ltd | Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo |
| JP2012526832A (ja) * | 2009-05-13 | 2012-11-01 | スノビオン プハルマセウトイカルス インコーポレイテッド | トランスノルセルトラリン及びセロトニン受容体１ａ作動剤／拮抗剤を含む組成物及びその使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
| AU6776196A (en) * | 1995-08-16 | 1997-03-12 | Eli Lilly And Company | Potentiation of serotonin response |
-
1999
- 1999-04-14 SK SK1450-2000A patent/SK14502000A3/sk unknown
- 1999-04-14 WO PCT/US1999/006523 patent/WO1999058130A1/en not_active Application Discontinuation
- 1999-04-14 EP EP99917309A patent/EP1075264B1/en not_active Expired - Lifetime
- 1999-04-14 BR BR9909559-9A patent/BR9909559A/pt not_active Application Discontinuation
- 1999-04-14 SI SI9930716T patent/SI1075264T1/xx unknown
- 1999-04-14 CN CN99805216A patent/CN1300217A/zh active Pending
- 1999-04-14 NZ NZ508035A patent/NZ508035A/xx unknown
- 1999-04-14 PT PT99917309T patent/PT1075264E/pt unknown
- 1999-04-14 JP JP2000547981A patent/JP2002514601A/ja not_active Withdrawn
- 1999-04-14 DE DE69922367T patent/DE69922367T2/de not_active Expired - Fee Related
- 1999-04-14 TR TR2000/03262T patent/TR200003262T2/xx unknown
- 1999-04-14 AU AU35460/99A patent/AU764579B2/en not_active Ceased
- 1999-04-14 AT AT99917309T patent/ATE283694T1/de not_active IP Right Cessation
- 1999-04-14 HU HU0101341A patent/HUP0101341A3/hu unknown
- 1999-04-14 KR KR1020007012418A patent/KR20010052319A/ko not_active Application Discontinuation
- 1999-04-14 ES ES99917309T patent/ES2232128T3/es not_active Expired - Lifetime
- 1999-04-14 CA CA002326105A patent/CA2326105A1/en not_active Abandoned
- 1999-04-14 IL IL13921199A patent/IL139211A0/xx not_active IP Right Cessation
- 1999-04-14 PL PL99345351A patent/PL345351A1/xx not_active Application Discontinuation
- 1999-04-14 EA EA200001162A patent/EA003469B1/ru not_active IP Right Cessation
-
2000
- 2000-09-29 ZA ZA200005301A patent/ZA200005301B/en unknown
- 2000-11-07 NO NO20005621A patent/NO20005621D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK14502000A3 (sk) | 2001-05-10 |
| EA003469B1 (ru) | 2003-06-26 |
| KR20010052319A (ko) | 2001-06-25 |
| CN1300217A (zh) | 2001-06-20 |
| NZ508035A (en) | 2004-02-27 |
| JP2002514601A (ja) | 2002-05-21 |
| AU764579B2 (en) | 2003-08-21 |
| ZA200005301B (en) | 2001-10-01 |
| BR9909559A (pt) | 2000-12-19 |
| EP1075264B1 (en) | 2004-12-01 |
| IL139211A0 (en) | 2001-11-25 |
| CA2326105A1 (en) | 1999-11-18 |
| HUP0101341A2 (hu) | 2001-08-28 |
| SI1075264T1 (en) | 2005-06-30 |
| DE69922367D1 (de) | 2005-01-05 |
| PL345351A1 (en) | 2001-12-17 |
| ATE283694T1 (de) | 2004-12-15 |
| TR200003262T2 (tr) | 2001-03-21 |
| HUP0101341A3 (en) | 2006-07-28 |
| WO1999058130A1 (en) | 1999-11-18 |
| DE69922367T2 (de) | 2005-12-22 |
| AU3546099A (en) | 1999-11-29 |
| ES2232128T3 (es) | 2005-05-16 |
| NO20005621L (no) | 2000-11-07 |
| NO20005621D0 (no) | 2000-11-07 |
| EP1075264A1 (en) | 2001-02-14 |
| EA200001162A1 (ru) | 2001-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY141992A (en) | 6-substituted 2,3,4,5-tetrahydro-1h-benzo [d] azepines as 5-ht2c receptor agonists | |
| RS20120158A3 (en) | Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors | |
| NO20054913L (no) | Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser | |
| DE602005027714D1 (de) | Verwendung von memantin (namenda) zur behandlung von autismus, zwangsverhalten und impulsivität | |
| HK1089177A1 (en) | Modulators of peripheral 5-ht receptors | |
| ATE442148T1 (de) | Kombinationstherapie durch glukoseresorptionshemmer und retinoid x rezeptorenmodulatoren | |
| PT1075264E (pt) | Novas combinacoes farmacologicas de reboxetina e pindolol | |
| DE60231107D1 (de) | Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems | |
| DE60111690D1 (de) | Katalysator für die Dampfreformierung von Methanol und Methode zur Herstellung von Wasserstoff mit diesem Katalysator | |
| NO20070914L (no) | Fremgangsmater for behandling av nervesystemforstyrrelser og tilstander | |
| NO20055206L (no) | 4-(2-fenyloksyfenyl)-piperidin eller -1,2,3,6-tetrahydropyridinderivater som serotonin-reopptaksinhibitorer | |
| ATE271865T1 (de) | Verwendung von cholinesterasehemmern zur behandlung von aufmerksamkeitsmangel-störungen | |
| BR0214182A (pt) | Processo para a preparação de tetraidrofurano ou mistura de tetraidrofurano, e seus precursores | |
| NO20051215L (no) | Katalysator for nedbryting av N2O i Ostwald-prosessen | |
| MY136367A (en) | Treatment of cognitive failure | |
| WO2002040006A3 (en) | Treatment of anxiety disorders | |
| DK1071418T3 (da) | Nye behandlinger til nervelidelser | |
| NO20085172L (no) | 3-(1h-indol-3-yl)indan-1-ylaminderivater for behandlingen av depresjon og angst | |
| ATE291920T1 (de) | Verwendung von quetiapin für aufmerksamkeitsmangel-hyperaktivitätsstörungen oder verhaltensstörungen | |
| AU2002347984A1 (en) | Use of norepinephrine reuptake inhibitors for the treatment of tic disorders | |
| PT1282414E (pt) | Compostos derivados de felbamato para o tratamento da dor neuropatica | |
| PE20030364A1 (es) | Sistemas de indan-1-ol varias veces sustituidos y procedimiento para su preparacion | |
| DE50211837D1 (de) | Xenogene oligo- oder/und polyribonukleotide als mittel zur behandlung von malignen tumoren | |
| UA81472C2 (en) | 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors | |
| ES1043843Y (es) | Generador de ruido blanco para la terapia del tinnitus. |